The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...
In little more than five years, German biotechnology company YUMAB (a phonetic play on HUMAB (human monoclonal antibody) in which the “Y” symbolizes the antibody structure) has become a global ...
An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...
Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...
Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...